Vitalhub Corp (VHI : TSX)
Common Stock
$7.24
CAD
+0.07 (0.98%)
Last updated: 2026-06-08
VHI
Vitalhub Corp
WealthAwesomePerformance
1 Day
+0.98%
1 Week
-4.99%
1 Month
-9.50%
YTD
-24.11%
Key Statistics
Market Cap
$450.41M
52W High
$14.64
52W Low
$6.67
P/E Ratio
59.33
50 Day MA
$7.50
200 Day MA
$9.15
Beta
0.77
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/8/2026 | $7.15 | $7.35 | $7.08 | $7.24 | $7.24 | 201,111 |
| 6/5/2026 | $7.30 | $7.32 | $7.07 | $7.17 | $7.17 | 205,024 |
| 6/4/2026 | $7.04 | $7.43 | $7.00 | $7.33 | $7.33 | 278,654 |
| 6/3/2026 | $7.40 | $7.40 | $6.85 | $7.00 | $7.00 | 791,010 |
| 6/2/2026 | $7.51 | $7.61 | $7.30 | $7.46 | $7.46 | 346,493 |
| 6/1/2026 | $7.55 | $7.75 | $7.45 | $7.62 | $7.62 | 308,595 |
| 5/29/2026 | $7.35 | $7.58 | $7.21 | $7.48 | $7.48 | 406,172 |
| 5/28/2026 | $7.30 | $7.51 | $7.15 | $7.29 | $7.29 | 412,274 |
| 5/27/2026 | $7.44 | $7.80 | $7.31 | $7.32 | $7.32 | 693,187 |
| 5/26/2026 | $7.17 | $7.53 | $7.06 | $7.49 | $7.49 | 651,643 |
Analyst Price Targets
Based on analyst covering VHI
Wall Street analysts forecast VHI stock price to rise 70.2% over the next 12 months.
Consensus
No RatingAvg. Target
C$12.32
+70.2% Upside
Current Price
C$7.24
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VHI's historical volatility
30-Day Vol
38.1%
Annualized
90-Day Vol
41.6%
Annualized
Trend (90d)
-47.1%
Annualized drift
90d Mean
C$6.12
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$6.84 | C$6.00 โ C$7.81 |
| 60 trading days | C$6.47 | C$5.37 โ C$7.79 |
| 90 trading days | C$6.12 | C$4.87 โ C$7.68 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Vitalhub Corp
Vitalhub Corp., together with its subsidiaries, provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. The company offers patient flow, operational visibility, and patient journey optimization solutions for hospital and integrated health environments, including SHREWD, Intouch with Health, Strata Health, MedCurrent, Beautiful Information, My Pathway, BookWise Solutions, Jayex Acute, MCAP, and Oculys. It also provides electronic healthcare record, case management, care coordination, and optimization solutions to inpatient/outpatient care providers, long-term care, and community and social services focused organizations, such as TREAT, CaseWORKS, clarity, Community Data Solutions, S12, B Care, DOCit, hicom, Clarity Healthcare Solutions, and Pirouette. In addition, the company offers a workforce automation and compliance suite that integrates and centralizes workforce and compliance data, which includes Hicom, Premier IT, and BookWise. Vitalhub Corp. was founded in 2010 and is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $119.20M
- EBITDA
- $23.28M
- Profit Margin
- 6.13%
- ROE (TTM)
- 3.25%
- EPS (Diluted)
- 0.12
- Book Value
- 4.21
Classification
- Sector
- Health Care
- Industry
- Health Care Technology
- Group
- Health Care Equipment & Services
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About VHI
Articles Featuring VHI.TO
Latest articles and analysis covering VHI.TO
Why Vitalhub Corp stock is rising today
Vitalhub Corp's stock rose by 3.04% in the latest trading session, driven by strong financial results and a positive outlook in the healthcare technology sector.
Why Vitalhub Corp stock is rising today
Vitalhub Corp's stock rose by 2.23% today, closing at CA$7.33, driven by strong financial results and investor optimism.
